H. Nüßlein

1.3k total citations
62 papers, 750 citations indexed

About

H. Nüßlein is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, H. Nüßlein has authored 62 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 18 papers in Pathology and Forensic Medicine and 15 papers in Genetics. Recurrent topics in H. Nüßlein's work include Rheumatoid Arthritis Research and Therapies (21 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). H. Nüßlein is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (21 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). H. Nüßlein collaborates with scholars based in Germany, France and Italy. H. Nüßlein's co-authors include Bernhard Manger, Rieke Alten, C. Rauch, Joachim R. Kalden, M. Chartier, Manuela Le Bars, Mauro Galeazzi, Coralie Poncet, Hans L. Spiegelberg and Hanns‐Martin Lorenz and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Journal of Immunology and Allergy.

In The Last Decade

H. Nüßlein

58 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Nüßlein Germany 16 415 174 132 108 104 62 750
Henrique Luiz Staub Brazil 17 497 1.2× 203 1.2× 226 1.7× 53 0.5× 35 0.3× 77 845
Y. Shoenfeld Israel 15 224 0.5× 274 1.6× 143 1.1× 117 1.1× 42 0.4× 38 842
Anikó Kapitány Hungary 22 402 1.0× 234 1.3× 41 0.3× 101 0.9× 39 0.4× 41 1.2k
Fiona Goldblatt Australia 15 438 1.1× 232 1.3× 90 0.7× 186 1.7× 55 0.5× 24 957
Youssef M. Mosaad Egypt 20 248 0.6× 400 2.3× 132 1.0× 114 1.1× 40 0.4× 56 941
Toshihiko Kaneshige Japan 17 196 0.5× 411 2.4× 234 1.8× 67 0.6× 71 0.7× 37 1.0k
Conleth Feighery Ireland 16 372 0.9× 297 1.7× 147 1.1× 51 0.5× 19 0.2× 24 995
A Laffón Spain 17 444 1.1× 281 1.6× 111 0.8× 91 0.8× 29 0.3× 30 1.1k
Masahiko Suzuki Japan 19 134 0.3× 263 1.5× 282 2.1× 46 0.4× 54 0.5× 72 995
J Pinkhas Israel 13 181 0.4× 213 1.2× 118 0.9× 43 0.4× 68 0.7× 60 627

Countries citing papers authored by H. Nüßlein

Since Specialization
Citations

This map shows the geographic impact of H. Nüßlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Nüßlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Nüßlein more than expected).

Fields of papers citing papers by H. Nüßlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Nüßlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Nüßlein. The network helps show where H. Nüßlein may publish in the future.

Co-authorship network of co-authors of H. Nüßlein

This figure shows the co-authorship network connecting the top 25 collaborators of H. Nüßlein. A scholar is included among the top collaborators of H. Nüßlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Nüßlein. H. Nüßlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alten, Rieke, Hans‐Peter Tony, Bettina Bannert, et al.. (2023). Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus. Clinical Rheumatology. 42(9). 2321–2334. 1 indexed citations
2.
Alten, Rieke, Eugen Feist, Hanns‐Martin Lorenz, et al.. (2019). Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries. Clinical Rheumatology. 38(11). 3049–3059. 5 indexed citations
3.
Peichl, P., Rieke Alten, Mauro Galeazzi, et al.. (2019). Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study. Wiener Medizinische Wochenschrift. 170(5-6). 132–140. 6 indexed citations
4.
Alten, Rieke, Xavier Mariette, Hanns‐Martin Lorenz, et al.. (2019). Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study. Clinical Rheumatology. 38(5). 1413–1424. 27 indexed citations
5.
Kiltz, Uta, Rieke Alten, Martin Fleck, et al.. (2017). Evidenzbasierte Empfehlung zur Diagnostik und Therapie der Gichtarthritis im fachärztlichen Sektor. Zeitschrift für Rheumatologie. 76(2). 118–124. 12 indexed citations
6.
Kiltz, Uta, Rieke Alten, Marcelo P. Fleck, et al.. (2016). [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].. PubMed. 75 Suppl 2. 11–60. 17 indexed citations
7.
8.
Nüßlein, H., Rieke Alten, Mauro Galeazzi, et al.. (2015). Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. BMC Musculoskeletal Disorders. 16(1). 176–176. 34 indexed citations
9.
Nüßlein, H., Rieke Alten, Mauro Galeazzi, et al.. (2014). Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study. BMC Musculoskeletal Disorders. 15(1). 14–14. 41 indexed citations
10.
Tarner, Ingo H., Katinka Albrecht, Martin Fleck, et al.. (2014). Evidenzbasierte Empfehlungen zum Management einer undifferenzierten peripheren entzündlichen Arthritis (UPIA). Zeitschrift für Rheumatologie. 73(4). 363–373.
11.
Proft, Fabian, Silke Steinbach, Claudia Dechant, et al.. (2014). Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener’s). Scandinavian Journal of Rheumatology. 43(6). 512–518. 12 indexed citations
12.
Nüßlein, H.. (2012). Wie früh würden wir Biologika wirklich einsetzen?. Zeitschrift für Rheumatologie. 71(10). 838–839. 2 indexed citations
13.
Manger, Karin, H. Nüßlein, Georg Schett, & Bernhard Manger. (2009). Rare monogenetic syndromes in rheumatology practice. Clinical Rheumatology. 28(6). 623–630. 5 indexed citations
14.
Manger, Bernhard, et al.. (2007). Neufassung der Empfehlungen der Kommission Pharmakotherapie der DGRh. Zeitschrift für Rheumatologie. 66(1). 72–75. 11 indexed citations
15.
Unger, L., et al.. (2005). Glucocorticoidtherapie bei Kollagenosen. Zeitschrift für Rheumatologie. 64(3). 162–169. 3 indexed citations
16.
Schwarz-Eywill, Michael, et al.. (2000). Die Relevanz einer standardisierten Staging-Untersuchung bei Patienten mit systemischer Vaskulitis. Zeitschrift für Rheumatologie. 59(3). 183–190. 1 indexed citations
17.
Beuche, Wolfgang, et al.. (1995). Origin and Immunoregulation of Autoantibodies Against Intestinal Alkaline Phosphatase. Scandinavian Journal of Immunology. 41(4). 414–420. 4 indexed citations
18.
Klebl, Franz, Griffin M. Weber, Joachim R. Kalden, & H. Nüßlein. (1994). In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion. Clinical & Experimental Allergy. 24(11). 1022–1029. 24 indexed citations
19.
Nüßlein, H., et al.. (1991). Interleukin-4-Induced IgG Subclass and IgE Secretion by Mononuclear Cells from Atopic Donors. International Archives of Allergy and Immunology. 95(2-3). 257–260. 11 indexed citations
20.
Nüßlein, H. & Hans L. Spiegelberg. (1990). Interleukin‐4 induces both lgg4 and ige secretion by peripheral blood b cells. Journal of Clinical Laboratory Analysis. 4(6). 414–419. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrique Luiz Staub Breakdown of academic impact, for papers by Y. Shoenfeld Breakdown of academic impact, for papers by Anikó Kapitány Breakdown of academic impact, for papers by Fiona Goldblatt Breakdown of academic impact, for papers by Youssef M. Mosaad Breakdown of academic impact, for papers by Toshihiko Kaneshige Breakdown of academic impact, for papers by Conleth Feighery Breakdown of academic impact, for papers by A Laffón Breakdown of academic impact, for papers by Masahiko Suzuki Breakdown of academic impact, for papers by J Pinkhas
Rankless by CCL
2026